GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Amplitude Surgical (XPAR:AMPLI) » Definitions » EV-to-Revenue

Amplitude Surgical (XPAR:AMPLI) EV-to-Revenue : 2.12 (As of May. 09, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Amplitude Surgical EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Amplitude Surgical's enterprise value is €220.7 Mil. Amplitude Surgical's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €104.0 Mil. Therefore, Amplitude Surgical's EV-to-Revenue for today is 2.12.

The historical rank and industry rank for Amplitude Surgical's EV-to-Revenue or its related term are showing as below:

XPAR:AMPLI' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.5   Med: 2.58   Max: 4.64
Current: 2.12

During the past 13 years, the highest EV-to-Revenue of Amplitude Surgical was 4.64. The lowest was 1.50. And the median was 2.58.

XPAR:AMPLI's EV-to-Revenue is ranked better than
62.71% of 826 companies
in the Medical Devices & Instruments industry
Industry Median: 3.19 vs XPAR:AMPLI: 2.12

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-09), Amplitude Surgical's stock price is €2.90. Amplitude Surgical's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €2.17. Therefore, Amplitude Surgical's PS Ratio for today is 1.34.


Amplitude Surgical EV-to-Revenue Historical Data

The historical data trend for Amplitude Surgical's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amplitude Surgical EV-to-Revenue Chart

Amplitude Surgical Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.93 2.04 2.67 2.88 2.28

Amplitude Surgical Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 2.88 - 2.28 -

Competitive Comparison of Amplitude Surgical's EV-to-Revenue

For the Medical Instruments & Supplies subindustry, Amplitude Surgical's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amplitude Surgical's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Amplitude Surgical's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Amplitude Surgical's EV-to-Revenue falls into.



Amplitude Surgical EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Amplitude Surgical's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=220.683/104.048
=2.12

Amplitude Surgical's current Enterprise Value is €220.7 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Amplitude Surgical's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €104.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Amplitude Surgical  (XPAR:AMPLI) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Amplitude Surgical's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=2.90/2.167
=1.34

Amplitude Surgical's share price for today is €2.90.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was €2.17.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Amplitude Surgical EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Amplitude Surgical's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Amplitude Surgical (XPAR:AMPLI) Business Description

Traded in Other Exchanges
Address
11 cours Jacques Offenbach, Valence, FRA, 26000
Amplitude Surgical is engaged in developing and marketing products for orthopedic surgery. It offers a range of orthopedic products for primary and revision surgery aimed at treating pathologies of the hip, knee, and lower extremities for foot and ankle surgery. The company also provides AMPLIVISION, a computer-assisted surgical system; the i.M.A.G.E., a single-use made-to-measure instrument system; and the E.T.O.I.L.E, a technology platform for anterior approaches resulting in less-invasive surgery.

Amplitude Surgical (XPAR:AMPLI) Headlines

No Headlines